Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sclera | 12 | 2024 | 57 | 4.240 |
Why?
|
| Contact Lenses | 9 | 2024 | 71 | 3.930 |
Why?
|
| Contact Lenses, Hydrophilic | 5 | 2023 | 78 | 1.740 |
Why?
|
| Intraocular Pressure | 2 | 2021 | 62 | 1.340 |
Why?
|
| Cornea | 5 | 2024 | 140 | 1.250 |
Why?
|
| Tomography, Optical Coherence | 4 | 2024 | 217 | 1.040 |
Why?
|
| Tears | 3 | 2021 | 21 | 0.990 |
Why?
|
| Prosthesis Fitting | 5 | 2021 | 23 | 0.880 |
Why?
|
| Humans | 16 | 2024 | 5476 | 0.870 |
Why?
|
| Epithelium, Corneal | 1 | 2024 | 13 | 0.860 |
Why?
|
| Corneal Stroma | 1 | 2024 | 17 | 0.850 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 68 | 0.750 |
Why?
|
| Hyperemia | 1 | 2021 | 4 | 0.720 |
Why?
|
| Glaucoma | 1 | 2021 | 40 | 0.700 |
Why?
|
| Optic Disk | 1 | 2020 | 59 | 0.620 |
Why?
|
| Lens, Crystalline | 1 | 2019 | 34 | 0.610 |
Why?
|
| Adult | 6 | 2024 | 1683 | 0.550 |
Why?
|
| Conjunctiva | 3 | 2021 | 13 | 0.520 |
Why?
|
| Male | 7 | 2024 | 2765 | 0.490 |
Why?
|
| Young Adult | 5 | 2024 | 850 | 0.490 |
Why?
|
| Female | 7 | 2024 | 2811 | 0.490 |
Why?
|
| Conjunctival Diseases | 1 | 2015 | 4 | 0.480 |
Why?
|
| Eyelid Diseases | 1 | 2015 | 5 | 0.480 |
Why?
|
| Hypoxia | 1 | 2015 | 12 | 0.480 |
Why?
|
| Corneal Diseases | 1 | 2015 | 10 | 0.480 |
Why?
|
| Tonometry, Ocular | 2 | 2021 | 39 | 0.350 |
Why?
|
| Myopia | 2 | 2022 | 114 | 0.300 |
Why?
|
| Corneal Pachymetry | 1 | 2024 | 7 | 0.220 |
Why?
|
| Tissue Donors | 1 | 2024 | 11 | 0.220 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2024 | 14 | 0.220 |
Why?
|
| Collagen | 1 | 2024 | 34 | 0.210 |
Why?
|
| Cells, Cultured | 1 | 2024 | 134 | 0.210 |
Why?
|
| Visual Acuity | 3 | 2021 | 179 | 0.200 |
Why?
|
| Time Factors | 2 | 2020 | 176 | 0.200 |
Why?
|
| Lipids | 1 | 2023 | 21 | 0.200 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 38 | 0.190 |
Why?
|
| Aged | 2 | 2024 | 859 | 0.190 |
Why?
|
| Middle Aged | 2 | 2024 | 1098 | 0.180 |
Why?
|
| Software | 1 | 2021 | 59 | 0.180 |
Why?
|
| Meibomian Glands | 1 | 2021 | 4 | 0.170 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 28 | 0.170 |
Why?
|
| Anterior Chamber | 1 | 2020 | 7 | 0.170 |
Why?
|
| Inflammation | 1 | 2020 | 59 | 0.160 |
Why?
|
| Retrospective Studies | 1 | 2021 | 382 | 0.160 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 5 | 0.150 |
Why?
|
| Patient Comfort | 1 | 2016 | 3 | 0.130 |
Why?
|
| Keratoconus | 1 | 2016 | 76 | 0.120 |
Why?
|
| Refractive Errors | 1 | 2015 | 58 | 0.110 |
Why?
|
| Child | 2 | 2022 | 657 | 0.070 |
Why?
|
| Eye | 1 | 2022 | 20 | 0.050 |
Why?
|
| Vision, Ocular | 1 | 2022 | 33 | 0.050 |
Why?
|
| Ohio | 1 | 2020 | 3 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 3 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 34 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 60 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 74 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2020 | 212 | 0.040 |
Why?
|
| Texas | 1 | 2020 | 190 | 0.040 |
Why?
|
| Refraction, Ocular | 1 | 2020 | 127 | 0.040 |
Why?
|
| Fluorophotometry | 1 | 2018 | 3 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 119 | 0.040 |
Why?
|
| Health Surveys | 1 | 2016 | 13 | 0.030 |
Why?
|
| Dry Eye Syndromes | 1 | 2016 | 12 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 277 | 0.030 |
Why?
|